Although Merck (Vioxx) invested in nearly twice as many ads as Pfizer (Celebrex) for the first nine months of 2000, advertising exposure for the two brands was roughly comparable over the remaining ...
The prestigious New England Journal of Medicine is publishing more criticism of a 2000 study on Vioxx. The journal says at least two researchers knew about "adverse cardiovascular events" more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results